F. Anthony Romero

Statistics

Publications

Citations

2.2K

H-Index

Active since

2002

Affiliations

Constellation Pharmaceuticals (United States)(Current)

WuXi AppTec (China)

Scripps Research Institute

University of Kansas

Gene Therapy Laboratory

F. Anthony Romero is an author at Constellation Pharmaceuticals (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

2002–2022

Publications

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

Ryan Raisner, Samir Kharbanda, Lingyan Jin et al. · Cell Reports · 2018 · 415 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors

F. Anthony Romero, Alexander M. Taylor, Terry D. Crawford et al. · Journal of Medicinal Chemistry · 2015 · 189 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +8

Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer

Lingyan Jin, Jesse Garcia, Emily Chan et al. · Cancer Research · 2017 · 152 citations · Full text

Medicine, Molecular Biology, Oncology +17

GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)

F. Anthony Romero, Jeremy Murray, Kwong Wah Lai et al. · Journal of Medicinal Chemistry · 2017 · 131 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 118 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–5 of 30